Katherine D. Crew
Experienced in Salpingo-Oophorectomy

Dr. Katherine D. Crew

Oncology
Trustees Of Columbia University In The City Of New York
622 W 168th St, 
New York, NY 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Experienced in Salpingo-Oophorectomy
Trustees Of Columbia University In The City Of New York
622 W 168th St, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Katherine Crew is an Oncologist in New York, New York. Dr. Crew is rated as an Experienced provider by MediFind in Salpingo-Oophorectomy. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Salpingo-Oophorectomy.

Her clinical research consists of co-authoring 151 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Salpingo-Oophorectomy.

Specialties
Oncology
Licenses
Internal Medicine in NY
Hospital Affiliations
New York-Presbyterian Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
622 W 168th St, New York, NY 10032
Other Locations
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
161 Fort Washington Ave, New York, NY 10032

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Prospective Observational Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Prospective Observational Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Enrollment Status: Recruiting
Publish Date: October 08, 2025
Intervention Type: Other, Drug
Study Drug: Carvedilol
Study Phase: Phase 3
Cluster Randomized Controlled Trial of Patient and Provider Decision Support to Increase Chemoprevention Informed Choice Among Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Making Informed Choices on Incorporating Chemoprevention Into Care (MiChoice)
Cluster Randomized Controlled Trial of Patient and Provider Decision Support to Increase Chemoprevention Informed Choice Among Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Making Informed Choices on Incorporating Chemoprevention Into Care (MiChoice)
Enrollment Status: Active_not_recruiting
Publish Date: September 17, 2025
Intervention Type: Other, Behavioral
Study Phase: Not Applicable
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Other, Procedure, Drug
Study Drugs: Entinostat, Exemestane, Goserelin, Goserelin Acetate
Study Phase: Phase 3
Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention Versus Placebo Control in Premenopausal Women
Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention Versus Placebo Control in Premenopausal Women
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Other, Drug
Study Drug: Metformin Hydrochloride
Study Phase: Phase 3
Topical Menthol for Chemotherapy Induced Peripheral Neuropathy (CIPN): A Randomized, Placebo Controlled Phase II Trial
Topical Menthol for Chemotherapy Induced Peripheral Neuropathy (CIPN): A Randomized, Placebo Controlled Phase II Trial
Enrollment Status: Terminated
Publish Date: July 11, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Study of 4-hydroxytamoxifen Topical Gel in Women With Mammographically Dense Breast
A Randomized, Double-Blind, Placebo-Controlled Study of 4-hydroxytamoxifen Topical Gel in Women With Mammographically Dense Breast
Enrollment Status: Completed
Publish Date: February 22, 2024
Intervention Type: Other, Drug
Study Drug: Afimoxifene
Study Phase: Phase 2
VADIS Trial: Phase II Trial of Nelipeimut-S Peptide Vaccine in Women With DCIS of the Breast
VADIS Trial: Phase II Trial of Nelipeimut-S Peptide Vaccine in Women With DCIS of the Breast
Enrollment Status: Completed
Publish Date: December 05, 2023
Intervention Type: Drug, Other, Biological, Procedure
Study Drugs: Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim
Study Phase: Phase 2
Alternative Dosing of Exemestane in Postmenopausal Women With Stage 0-II ER-Positive Breast Cancer: A Randomized Presurgical Trial
Alternative Dosing of Exemestane in Postmenopausal Women With Stage 0-II ER-Positive Breast Cancer: A Randomized Presurgical Trial
Enrollment Status: Completed
Publish Date: August 22, 2023
Intervention Type: Other, Drug, Procedure
Study Drug: Exemestane
Study Phase: Phase 2
Web-based Decision Aids for Breast Cancer Risk Assessment and Increasing Breast Cancer Chemoprevention in the Primary Care Setting: Randomized Controlled Trial
Web-based Decision Aids for Breast Cancer Risk Assessment and Increasing Breast Cancer Chemoprevention in the Primary Care Setting: Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: March 07, 2023
Intervention Type: Other
Study Phase: Not Applicable
A Study of the Beta-blocker Propranolol Alone and With Chemotherapy in Patients Receiving Neoadjuvant Treatment for Newly Diagnosed Breast Cancer
A Study of the Beta-blocker Propranolol Alone and With Chemotherapy in Patients Receiving Neoadjuvant Treatment for Newly Diagnosed Breast Cancer
Enrollment Status: Completed
Publish Date: September 10, 2021
Intervention Type: Drug, Other, Procedure
Study Drugs: Propranolol, Paclitaxel, Nab-Paclitaxel, Trastuzumab, Pertuzumab, Doxorubicin, Cyclophosphamide, Premedication, Anti-Nausea Therapy, Pegfilgrastim
Study Phase: Phase 2
Decision Support for BRCA Testing in Ethnically Diverse Women
Decision Support for BRCA Testing in Ethnically Diverse Women
Enrollment Status: Completed
Publish Date: April 19, 2021
Intervention Type: Other
Study Phase: Not Applicable
View 10 Less Clinical Trials

151 Total Publications

Germline Genetic Testing in Patients With Solid Malignant Tumors.
Germline Genetic Testing in Patients With Solid Malignant Tumors.
Journal: JAMA network open
Published: July 23, 2025
Similar Doctors
Kevin M. Holcomb
Distinguished in Salpingo-Oophorectomy
Dr. Kevin M. Holcomb
Oncology
Distinguished in Salpingo-Oophorectomy
Dr. Kevin M. Holcomb
Oncology

Northwell Health Physician Partners Gynecologic Oncology At New Hyde Park

9 Vermont Drive, 1st Floor, 
New Hyde Park, NY 
 (14.0 miles away)
516-812-3740
Languages Spoken:
English
See accepted insurances

Kevin Holcomb is an Oncologist in New Hyde Park, New York. Dr. Holcomb is rated as a Distinguished provider by MediFind in Salpingo-Oophorectomy. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Oophorectomy, and Salpingo-Oophorectomy.

Distinguished in Salpingo-Oophorectomy
Dr. Melissa K. Frey
Gynecologic Oncology | Obstetrics and Gynecology | Oncology
Distinguished in Salpingo-Oophorectomy
Dr. Melissa K. Frey
Gynecologic Oncology | Obstetrics and Gynecology | Oncology

Weill Medical College Of Cornell

525 E 68th St, 
New York, NY 
 (5.3 miles away)
212-746-7486
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Melissa Frey is a Gynecologic Oncologist and an Obstetrics and Gynecologist in New York, New York. Dr. Frey has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in Salpingo-Oophorectomy. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Lynch Syndrome, Salpingo-Oophorectomy, and Oophorectomy.

Distinguished in Salpingo-Oophorectomy
Dr. Douglas A. Levine
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Distinguished in Salpingo-Oophorectomy
Dr. Douglas A. Levine
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
1275 York Ave, 
New York, NY 
 (5.4 miles away)
646-227-3813
Languages Spoken:
English
See accepted insurances

Douglas Levine is a Gynecologic Oncologist and an Oncologist in New York, New York. Dr. Levine is rated as a Distinguished provider by MediFind in Salpingo-Oophorectomy. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Oophorectomy, and Salpingo-Oophorectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Crew's expertise for a condition
ConditionClose
View All 8 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile